Key facts
- It has raised $1.4M; the latest was Seed Round ($1.4M) in Apr 2025.
- Notable investors include Enlight Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Vespexx
- ·The full record, as it builds
Funding rounds
No funding rounds for Vespexx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vespexx
Provider of a relational health and wellness platform intended for couples to manage their reproductive health and daily lives together. The company's platform integrates a shared calendar with real-time synchronization, menstrual cycle tracking with emotional status sharing, and hormone monitoring through artificial intelligence and diagnostic hardware, enabling partners in the global wellness market to synchronize their health journeys and optimize family planning through data-driven collaborative insights.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Seoul, South Korea
- Founded
- 2023
- Employees
- 11
- Website
- vespexx.com/
- Ownership
- Privately Held (backing)
Vespexx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vespexx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vespexx in its N-PORT filings yet. We sweep new filings monthly.